Targeting B cell responses in universal influenza vaccine design
- 30 November 2011
- journal article
- review article
- Published by Elsevier BV in Trends in Immunology
- Vol. 32 (11), 524-531
- https://doi.org/10.1016/j.it.2011.08.007
Abstract
Since its first administration in the 1940s, the influenza vaccine has provided tremendous relief against influenza infections. However, time has revealed the ultimate limit of the vaccine and the call for its reinvention has now come, just as we are beginning to appreciate the antibody immune responses vital in preventing infections. New strategies to design the influenza vaccine rely on selectively inducing broadly neutralizing antibodies that are specific for highly conserved viral epitopes. Such approaches take us away from the limited range of protection provided by current seasonal influenza vaccines and towards a future with a pan-influenza vaccine capable of providing universal strain coverage.Keywords
This publication has 56 references indexed in Scilit:
- A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infectionAntiviral Research, 2010
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypesProceedings of the National Academy of Sciences of the United States of America, 2010
- Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesProceedings of the National Academy of Sciences of the United States of America, 2010
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeProceedings of the National Academy of Sciences of the United States of America, 2010
- Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virusNature Communications, 2010
- Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza VirusNew England Journal of Medicine, 2009
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivorsNature, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Fusion mutants of the influenza virus hemagglutinin glycoproteinCell, 1985